A Phase II Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula

NCT03174353 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Leak
Pancreatic Fistula
Pancreaticoduodenal; Fistula
Pancreatectomy; Hyperglycemia

Interventions

DRUG: Lanreotide Prefilled Syringe

Sponsor

University of Washington